- You can view the full Illumina Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
The squeeze is on these stocks, and they are poised for volatile moves.
Despite tepid market reaction, and analyst skepticism, there might be some upside for TMO.
Thermo Fisher Scientific (TMO) has reportedly offered $30 billion to acquire Illumina (ILMN).